Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2017 February;152(1) > Giornale Italiano di Dermatologia e Venereologia 2017 February;152(1):36-45

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

Rivista di Dermatologia e Malattie Sessualmente Trasmesse


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

REVIEW  


Giornale Italiano di Dermatologia e Venereologia 2017 February;152(1):36-45

DOI: 10.23736/S0392-0488.16.05425-0

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Melasma

Brian W. LEE 1, Robert A. SCHWARTZ 1, 2, Camila K. JANNIGER 1

1 Departments of Dermatology and Pathology, Rutgers University New Jersey Medical School, Newark, NJ, USA; 2 Rutgers University School of Public Affairs and Administration, Newark, NJ, USA


PDF  


Melasma is a common acquired hypermelanosis that primarily affects women of skin type IV-VI. It tends to appear on sun-exposed areas of face and neck. The exact pathogenesis is linked with many factors include ultraviolet radiation, pregnancy, hormonal activity, thyroid abnormalities, and medications. Melasma, which involves increased melanin production and melanocytosis, may be principally epidermal, dermal, or mixed. Mainstays of treatment include topical hypopigmenting agents, lasers, chemical peels, and dermabrasion.


KEY WORDS: Melanosis - Hyperpigmentation - Ultraviolet rays

inizio pagina

Publication History

Issue published online: December 13, 2016
Article first published online: September 3, 2016

Per citare questo articolo

Lee BW, Schwartz RA, Janniger CK. Melasma. G Ital Dermatol Venereol 2017;152:36-45. DOI: 10.23736/S0392-0488.16.05425-0

Corresponding author e-mail

cjanniger@yahoo.com